Carregant...
A comparison of letrozole and anastrozole followed by letrozole in breast cancer patients
BACKGROUND: We previously studied the noninferiority of anastrozole (ANZ) versus ANZ followed by letrozole (A-LTZ) due to reimbursement policy. We found that patients with A-LTZ had better overall survival (OS) than did patients with ANZ alone. This study aimed to prove that patients with A-LTZ also...
Guardat en:
| Publicat a: | Breast Cancer (Dove Med Press) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4309671/ https://ncbi.nlm.nih.gov/pubmed/25653555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S73997 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|